HK1199406A1 - Therapeutic agent for joint diseases - Google Patents
Therapeutic agent for joint diseasesInfo
- Publication number
- HK1199406A1 HK1199406A1 HK14113014.9A HK14113014A HK1199406A1 HK 1199406 A1 HK1199406 A1 HK 1199406A1 HK 14113014 A HK14113014 A HK 14113014A HK 1199406 A1 HK1199406 A1 HK 1199406A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- therapeutic agent
- joint diseases
- diseases
- joint
- therapeutic
- Prior art date
Links
- 208000012659 Joint disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011247047 | 2011-11-11 | ||
| PCT/JP2012/076478 WO2013069404A1 (ja) | 2011-11-11 | 2012-10-12 | 関節症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1199406A1 true HK1199406A1 (en) | 2015-07-03 |
Family
ID=48289788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14113014.9A HK1199406A1 (en) | 2011-11-11 | 2014-12-29 | Therapeutic agent for joint diseases |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9085593B2 (pt) |
| EP (1) | EP2803359B1 (pt) |
| JP (1) | JP5465815B2 (pt) |
| KR (1) | KR101953181B1 (pt) |
| CN (1) | CN103906519B (pt) |
| AU (1) | AU2012337087B2 (pt) |
| BR (1) | BR112014011315B8 (pt) |
| CA (1) | CA2855660C (pt) |
| ES (1) | ES2634008T3 (pt) |
| HK (1) | HK1199406A1 (pt) |
| IN (1) | IN2014CN04222A (pt) |
| MY (1) | MY168931A (pt) |
| RU (1) | RU2646457C2 (pt) |
| SG (1) | SG11201402226PA (pt) |
| WO (1) | WO2013069404A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI672313B (zh) | 2014-08-12 | 2019-09-21 | 日商大塚化學股份有限公司 | 環狀膦酸鈉鹽之結晶及其製造方法 |
| JPWO2021132297A1 (pt) | 2019-12-23 | 2021-07-01 | ||
| EP4252756A1 (en) | 2020-11-26 | 2023-10-04 | Sansho Co., Ltd. | Therapeutic agent for pulmonary fibrosis |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2700350B2 (ja) | 1990-04-20 | 1998-01-21 | 小糸工業株式会社 | 車両感知器 |
| JP3195833B2 (ja) | 1991-09-30 | 2001-08-06 | きみ子 室伏 | 新規生理活性物質及びその製造法 |
| JPH07149772A (ja) | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素ｃの活性促進剤 |
| JPH07258278A (ja) | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | １−Ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするＤＮＡポリメラーゼαの阻害剤 |
| JPH0925235A (ja) | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | １−ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
| JP2001178489A (ja) | 1999-12-24 | 2001-07-03 | Kimiko Murofushi | 環状ホスファチジン酸の製造法 |
| JP4815063B2 (ja) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び／又は生存の促進のための薬剤 |
| JP4836345B2 (ja) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 |
| US20040214799A1 (en) * | 2001-05-21 | 2004-10-28 | Mutsuko Mukai | Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives |
| JP4162927B2 (ja) * | 2002-06-11 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体 |
| RU2240131C1 (ru) * | 2003-04-04 | 2004-11-20 | Аладьев Сергей Иванович | Средство "артровит" для профилактики и лечения артритов и артрозов |
| AU2004229467B2 (en) * | 2003-04-11 | 2007-01-25 | The University Of Tennessee Research Foundation | Lysophosphatidic acid analogs and inhibition of neointima formation |
| RU2007134259A (ru) | 2005-02-16 | 2009-03-27 | Шеринг Корпорейшн (US) | Гетероциклические замещенные пиперазины, обладающие антагонистическим действием к cxcr3 |
| US20090326256A1 (en) * | 2006-12-28 | 2009-12-31 | Ochanomizu University | Analgesic agent comprising cyclic phosphatidic acid derivative |
| JP2010189315A (ja) * | 2009-02-18 | 2010-09-02 | Unitika Ltd | 関節軟骨損傷治癒促進剤及びそれを含有する飲食品 |
-
2012
- 2012-10-12 MY MYPI2014701211A patent/MY168931A/en unknown
- 2012-10-12 CN CN201280055135.7A patent/CN103906519B/zh active Active
- 2012-10-12 ES ES12847890.6T patent/ES2634008T3/es active Active
- 2012-10-12 CA CA2855660A patent/CA2855660C/en active Active
- 2012-10-12 BR BR112014011315A patent/BR112014011315B8/pt active IP Right Grant
- 2012-10-12 KR KR1020147015608A patent/KR101953181B1/ko active IP Right Grant
- 2012-10-12 IN IN4222CHN2014 patent/IN2014CN04222A/en unknown
- 2012-10-12 US US14/357,089 patent/US9085593B2/en active Active
- 2012-10-12 WO PCT/JP2012/076478 patent/WO2013069404A1/ja active Application Filing
- 2012-10-12 JP JP2013542900A patent/JP5465815B2/ja active Active
- 2012-10-12 RU RU2014123690A patent/RU2646457C2/ru active
- 2012-10-12 EP EP12847890.6A patent/EP2803359B1/en active Active
- 2012-10-12 SG SG11201402226PA patent/SG11201402226PA/en unknown
- 2012-10-12 AU AU2012337087A patent/AU2012337087B2/en active Active
-
2014
- 2014-12-29 HK HK14113014.9A patent/HK1199406A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2803359B1 (en) | 2017-04-19 |
| JPWO2013069404A1 (ja) | 2015-04-02 |
| KR101953181B1 (ko) | 2019-02-28 |
| CA2855660A1 (en) | 2013-05-16 |
| IN2014CN04222A (pt) | 2015-07-17 |
| BR112014011315B8 (pt) | 2020-09-15 |
| NZ624870A (en) | 2016-01-29 |
| US9085593B2 (en) | 2015-07-21 |
| MY168931A (en) | 2019-01-09 |
| BR112014011315A2 (pt) | 2017-05-09 |
| CN103906519A (zh) | 2014-07-02 |
| AU2012337087A1 (en) | 2014-06-05 |
| WO2013069404A1 (ja) | 2013-05-16 |
| BR112014011315B1 (pt) | 2020-03-03 |
| JP5465815B2 (ja) | 2014-04-09 |
| ES2634008T3 (es) | 2017-09-26 |
| RU2014123690A (ru) | 2015-12-20 |
| CN103906519B (zh) | 2017-10-10 |
| EP2803359A1 (en) | 2014-11-19 |
| RU2646457C2 (ru) | 2018-03-05 |
| US20140309194A1 (en) | 2014-10-16 |
| SG11201402226PA (en) | 2014-10-30 |
| KR20140098778A (ko) | 2014-08-08 |
| EP2803359A4 (en) | 2015-12-16 |
| CA2855660C (en) | 2019-04-16 |
| AU2012337087B2 (en) | 2016-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181615T1 (hr) | Terapijsko sredstvo koje izaziva citotoksičnost | |
| EP2740482A4 (en) | PROPHYLACTIC OR THERAPEUTIC FOR DISEASES OF THE MOUTH VALVE | |
| EP2673286A4 (en) | THERAPEUTIC COMPOUNDS | |
| GB201114212D0 (en) | Therapeutic agents | |
| EP2716441A4 (en) | JOINT BODY | |
| EP2666475A4 (en) | THERAPEUTIC AGENT FOR ALOPECIA | |
| GB201119401D0 (en) | Therapeutic agents | |
| IL227558A0 (en) | A therapeutic agent for tumors | |
| EP2740420A4 (en) | THERAPEUTIC TOOL | |
| EP2532652A4 (en) | THERAPEUTIC AGENT AGAINST HEPATITIS C | |
| ZA201502595B (en) | Therapeutic methods | |
| PL2723344T3 (pl) | Złożony środek leczniczy zawierający monoterpen | |
| HK1219224A1 (zh) | 角結膜病症的治療劑 | |
| EP2554163A4 (en) | THERAPEUTIC ACTIVE FOR NEURODEGENERATIVE DISEASES | |
| ZA201301458B (en) | Therapeutic agent for pain | |
| EP2601954A4 (en) | THERAPEUTIC FOR DISEASES | |
| HK1193053A1 (zh) | 過敏性鼻炎的治療劑 | |
| HK1199406A1 (en) | Therapeutic agent for joint diseases | |
| EP2815763A4 (en) | REMEDIES FOR INFLAMMATORY DISEASES | |
| EP2767283A4 (en) | THERAPEUTIC AND PROPHYLACTIC AGAINST DEMYELINISING DISEASE | |
| EP2599776A4 (en) | THERAPEUTIC AGENT FOR NEUROLOGICAL DISEASES | |
| EP2733207A4 (en) | THERAPEUTIC AGENT FOR ISCHEMIC DISEASE | |
| GB201115558D0 (en) | Therapeutic agents | |
| GB201110614D0 (en) | Therapeutic agents | |
| GB201101128D0 (en) | Therapeutic agents |